NCT06892951

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date: Jun 30, 2025
Primary completion: Jun 30, 2026
Completion date: Dec 31, 2028
First posted: Mar 25, 2025
Last posted: Mar 25, 2025
Enrollment: 100
Arms / groups: 3 / —
Source: AACT · ctgov ingestion

Sponsors

University Hospital, ToursLead sponsor
University of LilleCollaborator
University of Franche-ComtéCollaborator
University of BurgundyCollaborator
Hospital AvicenneCollaborator
University of Western BrittanyCollaborator
University of LimogesCollaborator
CHU Henri MondorCollaborator
University of VersaillesCollaborator
University of LyonCollaborator
University of PoitiersCollaborator
University of GrenobleCollaborator
University of AngersCollaborator
University of Picardie Jules VerneCollaborator
Sorbonne UniversityCollaborator
University of RennesCollaborator
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
University of ParisCollaborator
University of NantesCollaborator
University of BordeauxCollaborator
University of MontpellierCollaborator
AerogenCollaborator
University of Nice Sophia AntipolisCollaborator
University of ReimsCollaborator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.